Magellan Health (MGLN) Tops Q1 EPS Views; Updates FY15 Outlook

Magellan Health (NASDAQ: MGLN) reported Q1 EPS of $0.94, $0.55 better than the analyst estimate of $0.39. Revenue for the quarter came in at $981 million versus the consensus estimate of $1.02 billion.

Magellan Health sees FY2015 EPS of $3.41-$3.85, versus the consensus of $2.40. Magellan Health sees FY2015 revenue of $4.45-4.69 billion, versus the consensus of $4.47 billion.

For earnings history and earnings-related data on Magellan Health (MGLN) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• SVB & T Corporation (SVBT) Tops Q2 EPS by 275c
• JD.com (JD) Reiterated at Buy by Benchmark Amid Earnings Recovery